The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021. Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide.
- Agency -.
Complete Report on HIV Diagnosis Market spread across 137 Pages, Profiling 11 Companies and Supported with 72 Tables and 53 Figures is now available at www.rnrmarketresearch.com/hiv-diag…arket-report.html .
On the basis of test type, HIV diagnosis market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests.The antibody tests segment is expected to account for the largest share of the HIV diagnosis market in 2016.These tests are widely adopted to screening and confirmation of HIV antibodies.
Target Audience for this Report:
- Manufacturers of HIV Diagnosis Products
- Vendors and Distributors of Powered Surgical Instruments
- Research Institutes Related to HIV/AIDS Studies
- Venture Capitalists and Investors
This HIV diagnosis market report provides insights into the global HIV diagnosis market.
- Agency -.
The geographic analysis for these segments is also presented in this report. Leading players in market are profiled to study their product offerings and understand strategies undertaken by them to be competitive in this market.
Above-mentioned information would help buyer understand market dynamics.
Click Now for PDF Sample Download of this Study Report at
HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment.
Increasing prevalence of HIV/AIDS, increasing awareness about HIV, increasing blood donations and transfusions, and advancements in technology are expected to drive the growth of this market.
The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc.
(U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).
Access report @ www.rnrmarketresearch.com/contacts…hase?rname=911543 .
Geographically, North America dominates the global HIV diagnosis market. The government initiatives and funding in order to increase HIV diagnosis procedures and create awareness amongst the pollution and increasing number of blood transfusions are increasing the demand for HIV diagnosis products in North America.
The major factors contributing to the growth of the global HIV diagnosis market include the increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing government initiatives. On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market.
The high growth potential in the Asian region provides opportunities for players in the HIV diagnosis market.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: